Lv1
10 积分 2025-02-22 加入
EGFR molecular degraders: preclinical successes and the road ahead
8天前
已完结
Exploring Degradation of Mutant and Wild-Type Epidermal Growth Factor Receptors Induced by Proteolysis-Targeting Chimeras
23天前
已完结
Targeting the EGFR signaling pathway in cancer therapy: What’s new in 2023?
1个月前
已完结
Discovery of the novel celastrol-based PROTACs for the treatment of non-small cell lung cancer
1个月前
已完结
EGFR degraders in non‐small‐cell lung cancer: Breakthrough and unresolved issue
1个月前
已完结
Distinct Amino Acid-Based PROTACs Target Oncogenic Kinases for Degradation in Non-Small Cell Lung Cancer (NSCLC)
1个月前
已完结
Current advances of small molecule E3 ligands for proteolysis-targeting chimeras design
1个月前
已完结
Discovery of Potent PROTACs Targeting EGFR Mutants through the Optimization of Covalent EGFR Ligands
1个月前
已完结
Design and synthesis of proteolysis targeting chimeras (PROTACs) as an EGFR degrader based on CO-1686
1个月前
已完结
Exploring Degradation of Mutant and Wild-Type Epidermal Growth Factor Receptors Induced by Proteolysis-Targeting Chimeras
1个月前
已完结
皖公网安备34019202002308
